Hematobium schistosomiasis control for health management of labor force generation at Nkhotakota and Lilongwe in the Republic of Malawi—assumed to be related to occupational risk

In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be...

Full description

Saved in:
Bibliographic Details
Published inTropical medicine and health Vol. 47; no. 1; pp. 28 - 12
Main Authors Mishima, Nobuyuki, Jemu, Samuel K., Kuroda, Tomoaki, Tabuchi, Koichiro, Darcy, Andrew W., Shimono, Takaki, Lamaningao, Pheophet, Miyake, Mari, Kanda, Seiji, Ng’ambi, Susan, Komai, Yoshihiro, Maeba, Hirofumi, Amano, Hiroyuki, Nishiyama, Toshimasa
Format Journal Article
LanguageEnglish
Published Japan BioMed Central 02.05.2019
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective. The egg-positive prevalence was 34.3% (95% CI 28.5-40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2-17.3,  < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6-10.0,  < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1-6.9) to 0.9% (95% CI 0.3-3.4) and value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction. MDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers' health; the sound labor force generation is vital for economic growth and development in these areas and countries.
AbstractList Abstract Background In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective. Results The egg-positive prevalence was 34.3% (95% CI 28.5–40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2–17.3, p < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6–10.0, p < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1–6.9) to 0.9% (95% CI 0.3–3.4) and p value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction. Conclusions MDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers’ health; the sound labor force generation is vital for economic growth and development in these areas and countries.
Background In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective. Results The egg-positive prevalence was 34.3% (95% CI 28.5–40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2–17.3, p < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6–10.0, p < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1–6.9) to 0.9% (95% CI 0.3–3.4) and p value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction. Conclusions MDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers’ health; the sound labor force generation is vital for economic growth and development in these areas and countries.
In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective.BACKGROUNDIn Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective.The egg-positive prevalence was 34.3% (95% CI 28.5-40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2-17.3, p < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6-10.0, p < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1-6.9) to 0.9% (95% CI 0.3-3.4) and p value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction.RESULTSThe egg-positive prevalence was 34.3% (95% CI 28.5-40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2-17.3, p < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6-10.0, p < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1-6.9) to 0.9% (95% CI 0.3-3.4) and p value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction.MDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers' health; the sound labor force generation is vital for economic growth and development in these areas and countries.CONCLUSIONSMDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers' health; the sound labor force generation is vital for economic growth and development in these areas and countries.
In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective. The egg-positive prevalence was 34.3% (95% CI 28.5-40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2-17.3,  < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6-10.0,  < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1-6.9) to 0.9% (95% CI 0.3-3.4) and value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction. MDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers' health; the sound labor force generation is vital for economic growth and development in these areas and countries.
ArticleNumber 28
Author Komai, Yoshihiro
Nishiyama, Toshimasa
Kuroda, Tomoaki
Maeba, Hirofumi
Miyake, Mari
Mishima, Nobuyuki
Darcy, Andrew W.
Kanda, Seiji
Shimono, Takaki
Lamaningao, Pheophet
Amano, Hiroyuki
Ng’ambi, Susan
Jemu, Samuel K.
Tabuchi, Koichiro
Author_xml – sequence: 1
  givenname: Nobuyuki
  orcidid: 0000-0002-4331-1824
  surname: Mishima
  fullname: Mishima, Nobuyuki
– sequence: 2
  givenname: Samuel K.
  surname: Jemu
  fullname: Jemu, Samuel K.
– sequence: 3
  givenname: Tomoaki
  surname: Kuroda
  fullname: Kuroda, Tomoaki
– sequence: 4
  givenname: Koichiro
  surname: Tabuchi
  fullname: Tabuchi, Koichiro
– sequence: 5
  givenname: Andrew W.
  surname: Darcy
  fullname: Darcy, Andrew W.
– sequence: 6
  givenname: Takaki
  surname: Shimono
  fullname: Shimono, Takaki
– sequence: 7
  givenname: Pheophet
  surname: Lamaningao
  fullname: Lamaningao, Pheophet
– sequence: 8
  givenname: Mari
  surname: Miyake
  fullname: Miyake, Mari
– sequence: 9
  givenname: Seiji
  surname: Kanda
  fullname: Kanda, Seiji
– sequence: 10
  givenname: Susan
  surname: Ng’ambi
  fullname: Ng’ambi, Susan
– sequence: 11
  givenname: Yoshihiro
  surname: Komai
  fullname: Komai, Yoshihiro
– sequence: 12
  givenname: Hirofumi
  surname: Maeba
  fullname: Maeba, Hirofumi
– sequence: 13
  givenname: Hiroyuki
  surname: Amano
  fullname: Amano, Hiroyuki
– sequence: 14
  givenname: Toshimasa
  surname: Nishiyama
  fullname: Nishiyama, Toshimasa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31073271$$D View this record in MEDLINE/PubMed
BookMark eNp9ks-OFCEQxjtmjftHH8CLIfHiZRSabpq-mJiNupuMmhg9k2q6epoZGkag3XjzIXwUn8gnkZlZN7t78EAKqK9-UPCdFkfOOyyKp4y-ZEyKV7HKoVxQ1uZR1wv5oDhhvGoXFauao1vz4-I0xjWlnNeSPiqOOaMNLxt2Uvy-wAmS78w8kahHE5OPfjIQTSTauxS8JYMPZESwaSQTOFjhhC4RPxALXU7ltEayQocBkvGOQCIfN6NPsMmDgOvJ0ljvVldIjCNpRPIZt3Nnjd5BPoCFK_Pn5y-IcZ6wJ8mTDklAC-mw8lrP2z0aLAkmbh4XDwewEZ9cx7Pi67u3X84vFstP7y_P3ywXWjCWFmWjRVvWkgmqdVf1mtbQc60Zqxsqami1wEpDJ4EKNvQSAUWrERjjHYiK87Pi8sDtPazVNpgJwg_lwaj9hg8rBSEZbVGxXsq6b5se9kwtS6p5mQ8u5SBEqTPr9YGVO89d6vyEAewd6N2MM6Na-e9KVK0Uos6AF9eA4L_NGJOaTNRoLTj0c1RlyVlLW0nbLH1-T7r2c8ivl1V1JSRvJWdZ9ez2jW6u8s8cWcAOAh18jAGHGwmjamdAdTCgygZUOwMqmWuaezXapP3f5aaM_U_lX8wE5ME
CitedBy_id crossref_primary_10_1186_s12913_022_07925_3
crossref_primary_10_1186_s41182_022_00450_3
crossref_primary_10_1186_s12920_023_01711_8
Cites_doi 10.4269/ajtmh.1984.33.862
10.1016/0035-9203(89)90336-2
10.1186/1471-2334-11-169
10.1128/CMR.12.1.97
10.1186/s13071-014-0570-y
10.4314/mmj.v28i1.3
10.1016/j.pt.2003.10.002
10.1016/j.bjid.2014.11.004
10.1186/1756-3305-7-153
10.1016/S0022-5347(01)66763-6
10.1186/1471-2334-4-49
10.1186/1471-2334-4-40
10.1016/S2214-109X(17)30220-6
10.1542/peds.2014-3189
10.1016/S1473-3099(06)70521-7
10.1093/heapol/9.4.385
10.1016/S2214-109X(15)00047-9
10.1186/s13071-015-1165-y
10.1016/j.healthpol.2008.05.004
10.1371/journal.pntd.0002131
10.4269/ajtmh.2004.71.778
10.1016/S0140-6736(13)61949-2
10.1093/trstmh/trx037
10.1016/S0968-8080(06)27244-6
10.1016/S0035-9203(02)90229-4
10.1186/s40249-015-0053-1
10.1371/journal.pone.0143667
10.1007/s40647-016-0159-2
ContentType Journal Article
Copyright 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The Author(s) 2019
Copyright_xml – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
– notice: The Author(s) 2019
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s41182-019-0155-8
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Public Health Database (ProQuest)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Public Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1349-4147
EndPage 12
ExternalDocumentID oai_doaj_org_article_1d885d97da6e4cac820c3260c28f662c
PMC6498665
31073271
10_1186_s41182_019_0155_8
Genre Journal Article
GeographicLocations Malawi
Africa
GeographicLocations_xml – name: Africa
– name: Malawi
GrantInformation_xml – fundername: ;
  grantid: JP23406025
GroupedDBID ---
.55
0R~
123
29Q
2WC
53G
5VS
7X7
8C1
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFS
ACUHS
ADBBV
ADRAZ
ADUKV
AFKRA
AFPKN
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
ASPBG
AVWKF
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C6C
CCPQU
CITATION
CS3
DIK
DU5
DYU
E3Z
EBD
EBLON
EBS
ECGQY
EJD
ESX
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
ITC
JSF
JSH
KQ8
M48
OK1
OVT
OZF
PGMZT
PHGZM
PHGZT
PIMPY
RNS
ROL
RPM
RSV
SOJ
TR2
TUS
UKHRP
X7M
7.U
ACRMQ
AHSBF
AL-
C24
M~E
NPM
RJT
RZJ
TKC
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c611t-27c69258160ccb4dc05ad3cc1157065a9c6e4cab8a061fd8eae69cea113ba6433
IEDL.DBID M48
ISSN 1349-4147
1348-8945
IngestDate Wed Aug 27 01:26:09 EDT 2025
Thu Aug 21 18:12:49 EDT 2025
Fri Jul 11 10:56:24 EDT 2025
Fri Jul 25 22:21:57 EDT 2025
Thu Jan 02 22:54:32 EST 2025
Thu Apr 24 23:08:37 EDT 2025
Tue Jul 01 02:53:15 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Hematobium schistosomiasis
Labor health management
Economic growth
Malawi
Occupational risk
Urine reagent strips
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c611t-27c69258160ccb4dc05ad3cc1157065a9c6e4cab8a061fd8eae69cea113ba6433
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4331-1824
OpenAccessLink https://www.proquest.com/docview/2546839831?pq-origsite=%requestingapplication%
PMID 31073271
PQID 2546839831
PQPubID 5066164
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_1d885d97da6e4cac820c3260c28f662c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6498665
proquest_miscellaneous_2231909809
proquest_journals_2546839831
pubmed_primary_31073271
crossref_primary_10_1186_s41182_019_0155_8
crossref_citationtrail_10_1186_s41182_019_0155_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-05-02
PublicationDateYYYYMMDD 2019-05-02
PublicationDate_xml – month: 05
  year: 2019
  text: 2019-05-02
  day: 02
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Nagasaki
– name: London
PublicationTitle Tropical medicine and health
PublicationTitleAlternate Trop Med Health
PublicationYear 2019
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References C Bowie (155_CR22) 2004; 4
NC Lo (155_CR31) 2015; 3
H Guyatt (155_CR39) 1994; 9
MH Mostafa (155_CR3) 1999; 12
A Deribew (155_CR5) 2017; 55
CW Stecher (155_CR12) 2017; 111
AE Randall (155_CR26) 2002; 96
MG Chipeta (155_CR28) 2013; 7
DG Colley (155_CR4) 2014; 383
OJ Brady (155_CR37) 2017; 5
155_CR17
155_CR16
155_CR15
155_CR14
155_CR36
AA Fatiregun (155_CR40) 2009; 89
155_CR20
LA Tchuente (155_CR13) 2004; 71
P Makaula (155_CR33) 2014; 7
155_CR6
F Mutapi (155_CR25) 2015; 135
EC Faust (155_CR32) 1924; 3
155_CR8
VB Moyo (155_CR27) 2016; 28
155_CR9
AHN Mtethiwa (155_CR29) 2015; 4
L Savioli (155_CR38) 1989; 83
P Steinmann (155_CR11) 2006; 6
NM Koraitim (155_CR35) 1995; 154
155_CR2
Malawi Global Fund Coordinating Committee (155_CR19) 2002
AF Aenowo (155_CR7) 2015; 19
155_CR10
NR de Silva (155_CR1) 2003; 19
155_CR30
E Saathoff (155_CR23) 2004; 4
S Siziya (155_CR41) 1996; 42
S Dawaki (155_CR44) 2015; 10
LS Stephenson (155_CR42) 1984; 33
H Poole (155_CR21) 2014; 7
N Midzi (155_CR24) 2011; 11
SJ Krauth (155_CR43) 2015; 8
P Khurana (155_CR34) 1992; 95
D Palmer (155_CR18) 2006; 14
References_xml – ident: 155_CR6
– volume: 33
  start-page: 862
  issue: 5
  year: 1984
  ident: 155_CR42
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.1984.33.862
– volume: 83
  start-page: 805
  issue: 6
  year: 1989
  ident: 155_CR38
  publication-title: Trans R Soc Trop Med Hyg
  doi: 10.1016/0035-9203(89)90336-2
– ident: 155_CR8
– volume: 11
  start-page: 169
  year: 2011
  ident: 155_CR24
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-11-169
– ident: 155_CR10
– volume: 12
  start-page: 97
  issue: 1
  year: 1999
  ident: 155_CR3
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.12.1.97
– volume: 7
  start-page: 570
  year: 2014
  ident: 155_CR33
  publication-title: Parasit Vectors
  doi: 10.1186/s13071-014-0570-y
– volume: 28
  start-page: 10
  issue: 1
  year: 2016
  ident: 155_CR27
  publication-title: Malawi Med J
  doi: 10.4314/mmj.v28i1.3
– volume: 19
  start-page: 547
  issue: 12
  year: 2003
  ident: 155_CR1
  publication-title: Trends Parasitol
  doi: 10.1016/j.pt.2003.10.002
– volume: 19
  start-page: 196
  issue: 2
  year: 2015
  ident: 155_CR7
  publication-title: Braz J Infect Dis
  doi: 10.1016/j.bjid.2014.11.004
– volume: 55
  start-page: 3
  issue: suppl 1
  year: 2017
  ident: 155_CR5
  publication-title: Ethiop Med J
– ident: 155_CR14
– volume: 7
  start-page: 153
  year: 2014
  ident: 155_CR21
  publication-title: Parasit Vectors
  doi: 10.1186/1756-3305-7-153
– volume: 3
  start-page: 295
  year: 1924
  ident: 155_CR32
  publication-title: Am J Hyg
– volume: 154
  start-page: 1714
  year: 1995
  ident: 155_CR35
  publication-title: J Urol
  doi: 10.1016/S0022-5347(01)66763-6
– ident: 155_CR9
– volume: 4
  start-page: 49
  year: 2004
  ident: 155_CR22
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-4-49
– volume: 4
  start-page: 40
  year: 2004
  ident: 155_CR23
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-4-40
– volume: 95
  start-page: 149
  year: 1992
  ident: 155_CR34
  publication-title: J Trop Med Hyg
– volume-title: An Integrated Response to HIV/AIDS and Malaria: Application to the Global Fund. National AIDS Commission
  year: 2002
  ident: 155_CR19
– volume: 5
  start-page: e680
  year: 2017
  ident: 155_CR37
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(17)30220-6
– volume: 135
  start-page: 536
  issue: 3
  year: 2015
  ident: 155_CR25
  publication-title: PEDIATRICS
  doi: 10.1542/peds.2014-3189
– ident: 155_CR30
– volume: 6
  start-page: 411
  year: 2006
  ident: 155_CR11
  publication-title: Lancet
  doi: 10.1016/S1473-3099(06)70521-7
– volume: 9
  start-page: 385
  issue: 4
  year: 1994
  ident: 155_CR39
  publication-title: Health Policy Plan
  doi: 10.1093/heapol/9.4.385
– volume: 3
  start-page: e629
  year: 2015
  ident: 155_CR31
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(15)00047-9
– volume: 8
  start-page: 584
  year: 2015
  ident: 155_CR43
  publication-title: Parasit Vectors
  doi: 10.1186/s13071-015-1165-y
– volume: 89
  start-page: 72
  issue: 1
  year: 2009
  ident: 155_CR40
  publication-title: Health Policy
  doi: 10.1016/j.healthpol.2008.05.004
– volume: 7
  start-page: e2131
  issue: 3
  year: 2013
  ident: 155_CR28
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0002131
– volume: 71
  start-page: 778
  issue: 6
  year: 2004
  ident: 155_CR13
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.2004.71.778
– volume: 383
  start-page: 2253
  year: 2014
  ident: 155_CR4
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)61949-2
– volume: 111
  start-page: 144
  year: 2017
  ident: 155_CR12
  publication-title: Trans R Soc Trop Med Hyg
  doi: 10.1093/trstmh/trx037
– ident: 155_CR17
– volume: 14
  start-page: 27
  issue: 27
  year: 2006
  ident: 155_CR18
  publication-title: Reprod Health Matters
  doi: 10.1016/S0968-8080(06)27244-6
– volume: 96
  start-page: 29
  year: 2002
  ident: 155_CR26
  publication-title: Trans R Soc Trop Med Hyg
  doi: 10.1016/S0035-9203(02)90229-4
– ident: 155_CR15
– ident: 155_CR20
– volume: 4
  start-page: 25
  year: 2015
  ident: 155_CR29
  publication-title: Infectious Dis Poverty
  doi: 10.1186/s40249-015-0053-1
– volume: 10
  issue: 11
  year: 2015
  ident: 155_CR44
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0143667
– ident: 155_CR36
– ident: 155_CR2
– ident: 155_CR16
  doi: 10.1007/s40647-016-0159-2
– volume: 42
  start-page: 40
  issue: 2
  year: 1996
  ident: 155_CR41
  publication-title: Cent Afr J Med
SSID ssj0033580
Score 2.1195993
Snippet In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In...
Background In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged...
Abstract Background In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 28
SubjectTerms Age groups
Cooperation
Economic growth
GDP
Gross Domestic Product
Health education
Hematobium schistosomiasis
Infections
Infectious diseases
Labor force
Labor health management
Malawi
Occupational risk
Population
Poverty
Tropical diseases
Urinalysis
Urine
Urine reagent strips
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQD4gL4p-FggaJE1LU_Nmxj4CoVojtAVGpt8h_20bdTSqSVa99iD4KT8STMGNno12E4MIhh8RO5Pgb2581428Ye5vaqkytl4lZGpWU0tpEOnKx25CmXFkf8pAtTsT8tPx8xs92Un1RTFiUB44dd5Q5KblTldPCl1ZbXLEsUo7U5nIpRG5p9sU1b7uZinNwQc690YeZSXHUl8SjcdtMsUGcJ3JvFQpi_X9imL8HSu6sPMcP2P2RMsL72NSH7I5vH7G7i9Ep_pj9mJPuameazRpwr0paAX23bnTf9DBGogNSU4hHHmE9BbxAt4RgBFRsPZwHCWpCCvQAJ5cX3aAv8QLdOvjSrLr2_NpD0wKSRvjqo0I2fWShV_q6-Xlzi0wc5zoHQwfGQzgnE--6HTFjoHD2J-z0-NO3j_NkTMaQWJFlQ5JXVqicywy73prS2ZRrV1hLYj2IqlY24GOkRoawdNJrLxBpnWWF0Uh7iqfsoO1a_5yBd0qZnHzEuS9F6aXTvNCaC2U4N4WbsXQLTm1HpXJKmLGqw45FijriWSOeNeFZyxl7N71yFWU6_lb5AyE-VSSF7fAA7a4e7a7-l93N2OHWXupx2Pc1JRdAximLbMbeTMU4YMkLo1vfbbAOMmqVKpmqGXsWzWtqCXLtqsgrfLvaM7y9pu6XtM1FEAUXpSLpwhf_499esnt5GCt0eP-QHQzfN_4Vcq_BvA7D7BebKTFI
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagSIgL4r9bCjISJ6So-bNjnxAgqhVie0BU2ltkj73bqLtxabLqtQ_Bo_BEPAkexxu6CPWwh6ydyNE3tr_JjL8h5G0KVZmCFYleaJmUAiARBkPsEMqUS7ChDtnshE9Pyy9zNo8f3LqYVrldE8NCbRzgN_Ij1G33m7kosvcXPxKsGoXR1VhC4y65h9JlmNJVzUeHq8AQX3C4SpEIWbIY1cwEP-pKZNbekcZsIcYSsbMvBfn-_3HOf1Mnb-xFx4_Iw0gi6YcB9cfkjm2fkPuzGCZ_Sn5NUYnV6Wazpt57RfWAzq0b1TUdjbnp1JNVOhyCpOsxBYa6BQ1mgc1g6TKIUiN2VPX05PzM9erc_6hqDf3arFy7vLK0aamnkfSbHTSz8SEztVJXze_rn56b-9XP0N5RbWk4OTNcuRvyxhQT3J-R0-PP3z9Nk1ieIQGeZX2SV8BlzkTGUwBdGkiZMgUAyvd4nJUEbktQWijPGRZGWGW5x15lWaGVJ0LFc7LXutbuE2qNlDrHqHFuS15aYRQrlGJcasZ0YSYk3YJTQ9QuxxIaqzr4MILXA561x7NGPGsxIe_GWy4G4Y7bOn9ExMeOqLkd_nCXyzpO4TozQjAjK6PCe4HnTuDJbwq5WHCew4Qcbu2ljgtBV_812wl5Mzb7KYxxGdVat_F9PMeWqRSpnJAXg3mNI_Hsuyryyt9d7RjezlB3W9rmLMiE81KimOHB7cN6SR7kYRbgQf1Dstdfbuwrz7N6_TpMpj9FFyqh
  priority: 102
  providerName: ProQuest
Title Hematobium schistosomiasis control for health management of labor force generation at Nkhotakota and Lilongwe in the Republic of Malawi—assumed to be related to occupational risk
URI https://www.ncbi.nlm.nih.gov/pubmed/31073271
https://www.proquest.com/docview/2546839831
https://www.proquest.com/docview/2231909809
https://pubmed.ncbi.nlm.nih.gov/PMC6498665
https://doaj.org/article/1d885d97da6e4cac820c3260c28f662c
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBf9gNKXse9564IGexp484ckSw9jrKUljCWMskD3ZGRJSU0Te0scuv1b-wt3JzumGdkebLAlC8l3Z_3kO_2OkNeRyVhknAyLaaFCJo0JpUUXu_FpypVxPg_ZaCyGE_bpil_tkU16q-4FrnYu7TCf1GQ5f_vzx68PYPDvvcFL8W7FECXDohgjfzgP5T45hIkpQzsdsd6pkKLHz6-_mAylYrxzcu5s4pgcAfDJ0iSLt2YsT-y_C43-HVR5Z5a6uE_udfCSfmz14QHZc9VDcjTqHOiPyO8hcrTWRbleUBg88gqs6kWpV-WKdlHrFGAsbbdH0kUfHEPrKfUKg8XG0Zmnq0apUt3Q8c113egbOKiuLP1czutqdutoWVEAmPTStWza2MhIz_VtGQJmh6-ipU1NC0f9jpr2qr5De0wx8P0xmVycfz0bhl3ahtCIOG7CJDNCJVzGIjKmYNZEXNvUGKT1AflrZYRjRhdSA5aYWum0E6ATOo7TQgNASp-Qg6qu3DNCnVWqSNCbnDgmmJNW81RrLlTBeZHagEQb0eSm4zTH1Brz3K9tpMhbweYg2BwFm8uAvOkf-d4Sevyv8inKu6-IXNz-Rr2c5Z1p57GVkluVWe3HZQBTGQDFkUnkVIjEBORkoy35Rr9zTEMA2FSmcUBe9cVg2uiv0ZWr11AHsLeKlIxUQJ62ytX3ZKOcAcm21G6rq9slVXnt6cMFU0hy-Pyfbb4gx4m3BNy7f0IOmuXavQTo1RQDsp9dZXCWZ_GAHJ6ej79cDvxvDDx_mwy8wf0BxSYw1w
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxJtAgUWCC5JVP9e7B4R4VSlNckCtlNuy3t2kVhO71I4ibvwIfgcnfhG_hJn1gwah3nrwId61NdG8PbPfEPLC12nsa8u9bJYJL-Zae9xgiV27MeVCWzeHbDxhw6P40zSZbpGf3VkYbKvsbKIz1KbU-I18F3HbwZnzKHhz-tXDqVFYXe1GaDRicWC_rSFlq17vfwD-vgzDvY-H74deO1XA0ywIai9MNRNhwgPma53FRvuJMpHWiDoD5CmhmY21yrgCVzcz3CrLgGQVBFGmwH9H8N4r5Co4Xh81Kp32CV6EJUWX4MXc4yJO2ipqwNluFWMkD4k7diclicc3_KAbF_C_GPffVs1zvm_vFrnZBq30bSNlt8mWLe6Qa-O2LH-X_Boi8muZ5aslhWwZ0QqqcpmrKq9o2wtPITimzaFLuuxbbmg5o04McVlbOncg2CgrVNV0cnJc1uoELqoKQ0f5oizma0vzgkLYSj_bBqMbXzJWC7XOf3__AbkAWFtD65JmlrqTOs2v8hycMsWG-nvk6FIYd59sF2VhHxJqjRBZiFXq0MYsttyoJFIqYSJLkiwyA-J3zJG6xUrHkR0L6XImzmTDTwn8lMhPyQfkVf_IaQMUctHmd8jxfiNifLsb5dlctiZDBobzxIjUKPe_NMRqGoJtX4d8xlioB2SnkxfZGp5K_lWTAXneL4PJwDqQKmy5gj0Q0wtfcF8MyINGvHpKQKrTKEzh6XRD8DZI3Vwp8mMHS85igeCJjy4m6xm5Pjwcj-Rof3LwmNwInUYgSMAO2a7PVvYJxHh19tQpFiVfLluT_wB8Ymgm
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6VIlVcEP8NFFgkuCBZ8d-udw8IASVKaRMhRKXczHp3k1pN7FI7irjxEDwKJx6HJ2Fm7ZgGod568CHetTXR_HtmvyHkua-T2NdWeNk0k14stPaEwRK7dmPKpbZuDtlozIfH8YcJm2yRX-uzMNhWubaJzlCbUuM38j7itoMzF1HQn7ZtER_3B6_Pvno4QQorretxGo2IHNpvK0jfqlcH-8DrF2E4eP_53dBrJwx4mgdB7YWJ5jJkIuC-1llstM-UibRGBBogVUnNbaxVJhS4vakRVlkO5KsgiDIFvjyC914j15OIBahjyaRL9iIsL7pkLxaekDFrK6qB4P0qxqgeknjsVGLMExs-0Y0O-F-8-2_b5gU_OLhFbrYBLH3TSNxtsmWLO2Rn1Jbo75KfQ0SBLbN8uaCQOSNyQVUuclXlFW374ikEyrQ5gEkXXfsNLafUiSQua0tnDhAb5Yaqmo5PT8pancJFVWHoUT4vi9nK0rygEMLST7bB68aXjNRcrfLf339AXgCW19C6pJml7tRO86u8AK1Msbn-Hjm-EsbdJ9tFWdhdQq2RMguxYh3amMdWGMUipRiXGWNZZHrEXzMn1S1uOo7vmKcufxI8bfiZAj9T5GcqeuRl98hZAxpy2ea3yPFuI-J9uxvl-SxtzUcaGCGYkYlR7n9piNs0BN6-DsWU81D3yN5aXtLWCFXpX5XpkWfdMpgPrAmpwpZL2APxvfSl8GWPPGjEq6MEIv8kChN4OtkQvA1SN1eK_MRBlPNYIpDiw8vJekp2QIfTo4Px4SNyI3QKgXgBe2S7Pl_axxDu1dkTp1eUfLlqRf4DFh5sXA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hematobium+schistosomiasis+control+for+health+management+of+labor+force+generation+at+Nkhotakota+and+Lilongwe+in+the+Republic+of+Malawi-assumed+to+be+related+to+occupational+risk&rft.jtitle=Tropical+medicine+and+health&rft.au=Mishima%2C+Nobuyuki&rft.au=Jemu%2C+Samuel+K&rft.au=Kuroda%2C+Tomoaki&rft.au=Tabuchi%2C+Koichiro&rft.date=2019-05-02&rft.issn=1348-8945&rft.volume=47&rft.spage=28&rft_id=info:doi/10.1186%2Fs41182-019-0155-8&rft_id=info%3Apmid%2F31073271&rft.externalDocID=31073271
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1349-4147&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1349-4147&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1349-4147&client=summon